Quartz·1 min read·medium
Judge denied Novo Nordisk bid to block Eli Lilly weight-loss drug ads
✦AI Summary
A federal judge has denied Novo Nordisk's request to block Eli Lilly from advertising its weight-loss drugs. The judge ruled that Novo Nordisk failed to demonstrate that the advertisements caused irreparable harm, though the false advertising lawsuit remains active.
Why it matters
This ruling impacts the competitive landscape of the high-growth weight-loss drug market and sets a precedent for pharmaceutical advertising disputes.
Judge Zahid Quraishi said Novo Nordisk failed to show…
Also covering this story
One other newsroom covered this event. We read that version too.
businesshealth
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in